Severe Anaphylactic Reaction to Glatiramer Acetate with Specific IgE
Neurol 64:1481-1482, Rauschka,H.,et al, 2005

Autonomic Peripheral Neuropathy
Lancet 365:1259-1270, Freeman,R., 2005

Rehabilitation After Stroke
NEJM 352:1677-1684, Dobkin,B.H., 2005

Thrombolytic Therapy of Acute Ischemic Stroke: Correlation of Angiographic Recanalization with Clinical Outcome
AJNR 26:880-884, Zaidat,O.O.,et al, 2005

Mechanical Thrombectomy for Acute Stroke
AJNR 26:875-879, Versnick,E.J.,et al, 2005

Magnetic Susceptibility-Weighted MR Phase Imaging of the Human Brain
AJNR 26:736-742, Rauscher,A.,et al, 2005

Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005

Management of Depression After Stroke
Stroke 36:1092-1097, Hackett,M.L.,et al, 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005

Physical Methods for Preventing Deep Vein Thrombosis in Stroke
Stroke 36:1102-1103, Grandi,F.C.,et al, 2005

Myasthenia Gravis
JAMA 293:1940, Torpy,J.M., 2005

Does This Patient Have Myasthenia Gravis?
JAMA 293:1906-1914, Scherer,K.,et al, 2005

Persistent Low Back Pain
NEJM 352:1891-1898, Carragee,E.J., 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005

IV Thrombolysis in Patients with Acute Stroke Due to Spontaneous Carotid Dissection
Neurol 64:1612-1614, Georgiadis,D.,et al, 2005

FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005

The Ketogenic Diet
Neurologist 11:161-170, Sinha,S.R. &Kossof,E.H., 2005

Lipid-Lowering Agent Use at Ischemic Stroke Onset is Associated with Decreased Mortality
Neurol 65:253-258, Elkind,M.S.V.,et al, 2005

Epileptic Seizures During Follow-up of Patients Treated for Primary Brain Tumors
Neurol 65:213-215, Hildebrand,J.,et al, 2005

Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
NEJM 353:369-374,414,432, Kleinschemidt-DeMasters,B.K. &Tyler,K.L., 2005

Cerebral Venous Thrombosis: Influence of Risk Factors and Imaging Findings on Prognosis
Clin Neurol Neurosurg 107:371-378, Appenzeller,S.,et al, 2005

West Nile Virus Among Blood Donors in the United States, 2003 and 2004
NEJM 353:451-459,516, Stramer,S.L.,et al, 2005

Survival after Treatment of Rabies with Induction of Coma
NEJM 352:2508-2514,2549, Willoughby,Jr.,R.E.,et al, 2005

Isolated Monoparesis Following Stroke
JNNP 76:805-807, Paciaroni,M.,et al, 2005

Bells Palsy
BMJ 330:1374, Piercy, J, 2005

Vertigo
BMJ 330:523, Kanagalingam,J.,et al, 2005

Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005

Time to Hospital Arrival, Use of Thrombolytics, and In-Hospital Outcomes in Ischemic Stroke
Neurol 64:2115-2120, Qureshi,A.I.,et al, 2005

Searching for a Relationship Between Manganese and Welding and Parkinsons Disease
Neurol 64:2021-2028, 2001, Jankovic,J., 2005

Practice Parameter:Therapies for Essential Tremor
Neurol 64:2008-2020, Zesiewicz,T.A.,et al, 2005

A Randomized Controlled Trial of Surgery vs Steroid Injection for Carpal Tunnel Syndrome
Neurol 64:2074-2078,2006, Hui,A.C.F.,et al, 2005

Transcranial Low-Frequency Ultrasound-Mediated Thrombolysis in Brain Ischemia
Stroke 36:1441-1446, Daffertshofer,M.,et al, 2005

A Systematic Review of the Risk Factors for Cervical Artery Dissection
Stroke 36:1575-1580, Rubinstein,S.M.,et al, 2005

Recommendations for Comprehensive Stroke Centers, A Consensus Statement from the Brain Attach Coalition
Stroke 36:1597-1618, Alberts,M.J.,et al, 2005

Predictors of Early Arterial Reocclusion After Tissue Plasminogen Activator-Induced Recanalization in Acute Ischemic Stroke
Stroke 36:1452-1456, Rubiera,M.,et al, 2005

Neutralizing Anti-IFN-B Antibodies
Neurol 65:6-8, Giovannoni,G.&Goodman,A., 2005

Life-Threatening Acute Pancreatitis Associated with Interferon Beta-1a Treatment in Multiple Sclerosis
Neurol 65:170-171, Midgard,R.,et al, 2005

Statin Use and the Risk of Incident Dementia
Arch Neurol 62:1047-1051, Rea,T.D.,et al, 2005

Patent Foramen Ovale Closure Devices
JAMA 294:366-369, Maisel,W.H.&Laskey,W.K., 2005

CT and MRI Findings of Intracranial Lymphoma
AJR 184:1679-1685, Slone,H.W.,et al, 2005

Taste Disorders in Acute Stroke
Stroke 36:1690-1694, Heckmann, J.G.,et al, 2005

Prognosis and Decision Making in Severe Stroke
JAMA 294:725-733, Holloway,R.G.,et al, 2005

Pleuropulmonary Fibrosis After Long-term Treatment With the Dopamine Agonist Pergolide for Parkinson Disease
Arch Neurol 62:1290-1295, Tintner,R.,et al, 2005

Pure Monoparesis
Arch Neurol 62:1221-1224, Maeder-Ingvar,M.,et al, 2005

Effect of Discontinuing Aspirin Therapy on the Risk of Brain Ischemic Stroke
Arch Neurol 62:1217-1220, Maulaz,A.B.,et al, 2005

Supportive Care for Patients With Guillain-Barr Syndrome
Arch Neurol 62:1194-1198, Hughes,R.A.C.,et al, 2005

Camptocormia
Neurol 65:355-359, Azher,S.N. &Jankovic,J., 2005

Cervical Radiculopathy
NEJM 353:392-399, Carette,S. &Fehlings,M.G., 2005

Risk of Hemorrhagic Stroke With Aspirin Use
Stroke 36:1801-1807, Gorelick,P.B. &Weisman,S.M., 2005

Calcium Antagnosits in Aneurysmal Subarachnoid Hemorrhage
Stroke 36:1816-1817, Rinkel,G.J.E.,et al, 2005